Product Code: CHFR
The consumer health market continued to grow in France in current value terms in 2019, with growth at a very similar level to the previous two years. However, many players were concerned by two main negative factors. The first of which was limited ailments in 2018 and, to a lesser extent, in early 2019. The impact of cold and flu was lower due to the 2018/2019 season beginning much later in the year than expected. In addition, there has been a decline in self-medication.
Euromonitor International's ‘Consumer Health in France report’ offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Consumer Health market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market's major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
EXECUTIVE SUMMARY
- Consumer health continues to grow despite declining self-medication levels
- Reverse switches and trend towards more natural products
- Sanofi continues to lead
- Chemists/pharmacies continues to dominate distribution
- Continued current value growth expected over the forecast period
MARKET INDICATORS
- Table 1. Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
- Table 2. Life Expectancy at Birth 2014-2019
MARKET DATA
- Table 3. Sales of Consumer Health by Category: Value 2014-2019
- Table 4. Sales of Consumer Health by Category: % Value Growth 2014-2019
- Table 5. NBO Company Shares of Consumer Health: % Value 2015-2019
- Table 6. LBN Brand Shares of Consumer Health: % Value 2016-2019
- Table 7. Penetration of Private Label in Consumer Health by Category: % Value 2014-2019
- Table 8. Distribution of Consumer Health by Format: % Value 2014-2019
- Table 9. Distribution of Consumer Health by Format and Category: % Value 2019
- Table 10. Forecast Sales of Consumer Health by Category: Value 2019-2024
- Table 11. Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024
APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- Summary 1. OTC: Switches 2018-2019
DEFINITIONS
SOURCES
- Summary 2. Research Sources
HEADLINES
PROSPECTS
- Analgesics suffers from a weak flu season, the codeine-based combination products ban and ibuprofen's struggles
- Bad press means ibuprofen sales continue to decline
- Acetaminophen most dynamic as it benefits from the woes of the other analgesic types
COMPETITIVE LANDSCAPE
- Doliprane helps Sanofi to continue gaining share
- Laboratoires UPSA's share slips as it gets a new owner in Taisho Pharmaceutical Holdings
- Uncertain times for topical analgesics/anaesthetic
CATEGORY DATA
- Table 12. Sales of Analgesics by Category: Value 2014-2019
- Table 13. Sales of Analgesics by Category: % Value Growth 2014-2019
- Table 14. NBO Company Shares of Analgesics: % Value 2015-2019
- Table 15. LBN Brand Shares of Analgesics: % Value 2016-2019
- Table 16. Forecast Sales of Analgesics by Category: Value 2019-2024
- Table 17. Forecast Sales of Analgesics by Category: % Value Growth 2019-2024
HEADLINES
PROSPECTS
- Performance improves but sales still declining in cough, cold and allergy (hay fever) remedies
- After pharyngeal preparations and codeine-based products, now it is nasal sprays in the line of fire
- Antihistamines/allergy remedies (systemic) enjoys another year of dynamic growth
COMPETITIVE LANDSCAPE
- Leader Solinest continues to grow through its Ricola brand
- GSK's Cetirizin Sandoz records strong growth in 2019
- Flurbiprofen switched to prescription status
CATEGORY DATA
- Table 18. Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2014-2019
- Table 19. Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2014-2019
- Table 20. NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2019
- Table 21. LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2019
- Table 22. Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
- Table 23. Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024
HEADLINES
PROSPECTS
- OTC dermatologicals still growing despite competition from Rx and dermocosmetic products
- Increasing popularity of natural products
- Haemorrhoid treatments and antipruritics the most dynamic product areas
COMPETITIVE LANDSCAPE
- Johnson & Johnson extends its lead over Laboratoires Pierre Fabre in 2019
- Strong competition in antiparasitics/lice (head and body) treatments
- Cicatryl benefits from advertising support in topical germicidals/antiseptics
CATEGORY DATA
- Table 24. Sales of Dermatologicals by Category: Value 2014-2019
- Table 25. Sales of Dermatologicals by Category: % Value Growth 2014-2019
- Table 26. NBO Company Shares of Dermatologicals: % Value 2015-2019
- Table 27. LBN Brand Shares of Dermatologicals: % Value 2016-2019
- Table 28. LBN Brand Shares of Hair Loss Treatments: % Value 2016-2019
- Table 29. Forecast Sales of Dermatologicals by Category: Value 2019-2024
- Table 30. Forecast Sales of Dermatologicals by Category: % Value Growth 2019-2024
HEADLINES
PROSPECTS
- Dietary supplements enjoy a positive image among French consumers
- While consumers believe in them, some scientific bodies doubt the efficacy of dietary supplements
- Consumers increasingly taking dietary supplements for sleeping, stress, digestion and vitality
COMPETITIVE LANDSCAPE
- Ponroy Sante Group acquires Ersa and Densmore
- Chemists/Pharmacies still the most important distribution channel for dietary supplements
- Cuure looking to simplify taking dietary supplements for consumers
CATEGORY DATA
- Table 31. Sales of Dietary Supplements by Category: Value 2014-2019
- Table 32. Sales of Dietary Supplements by Category: % Value Growth 2014-2019
- Table 33. Sales of Dietary Supplements by Positioning: % Value 2014-2019
- Table 34. NBO Company Shares of Dietary Supplements: % Value 2015-2019
- Table 35. LBN Brand Shares of Dietary Supplements: % Value 2016-2019
- Table 36. Forecast Sales of Dietary Supplements by Category: Value 2019-2024
- Table 37. Forecast Sales of Dietary Supplements by Category: % Value Growth 2019-2024
HEADLINES
PROSPECTS
- Diarrhoeal remedies driving sales of digestive remedies
- Concerns about proton pump inhibitors and laxatives
- Motion sickness remedies growth supported by increasing levels of travel
COMPETITIVE LANDSCAPE
- Imodium and Gaviscon among the strong performers in 2019
- Macrogol-based products performing strongly in laxatives
- H2 blockers no longer available in OTC consumer health
CATEGORY DATA
- Table 38. Sales of Digestive Remedies by Category: Value 2014-2019
- Table 39. Sales of Digestive Remedies by Category: % Value Growth 2014-2019
- Table 40. NBO Company Shares of Digestive Remedies: % Value 2015-2019
- Table 41. LBN Brand Shares of Digestive Remedies: % Value 2016-2019
- Table 42. Forecast Sales of Digestive Remedies by Category: Value 2019-2024
- Table 43. Forecast Sales of Digestive Remedies by Category: % Value Growth 2019-2024
HEADLINES
PROSPECTS
- Medical devices for dry eye a dynamic area in standard eye care
- Antiseptic standard care performing well in 2019, but could do better
- Half of the local population could have allergies in the next 20 years
COMPETITIVE LANDSCAPE
- Laboratoires Chauvin's Aqualarm brand benefits from two new products
- Reckitt Benckiser's advertising spend on its Optone brand boosts this line's performance in 2019
- Companies innovate to gain share while generics suffer
CATEGORY DATA
- Table 44. Sales of Eye Care by Category: Value 2014-2019
- Table 45. Sales of Eye Care by Category: % Value Growth 2014-2019
- Table 46. NBO Company Shares of Eye Care: % Value 2015-2019
- Table 47. LBN Brand Shares of Eye Care: % Value 2016-2019
- Table 48. Forecast Sales of Eye Care by Category: Value 2019-2024
- Table 49. Forecast Sales of Eye Care by Category: % Value Growth 2019-2024
HEADLINES
PROSPECTS
- Herbal/traditional products seeing stronger growth than standard products
- Virtuous cycle of energy and calming products is boosting herbal sleep aids
- No tough new regulations expected on herbal products
COMPETITIVE LANDSCAPE
- Fragmented category led by Arkopharma
- Medicated confectionery line Ricola the leading brand
- Discounts, promotions and incentives both a blessing and a curse
CATEGORY DATA
- Table 50. Sales of Herbal/Traditional Products by Category: Value 2014-2019
- Table 51. Sales of Herbal/Traditional Products by Category: % Value Growth 2014-2019
- Table 52. NBO Company Shares of Herbal/Traditional Products: % Value 2015-2019
- Table 53. LBN Brand Shares of Herbal/Traditional Products: % Value 2016-2019
- Table 54. Forecast Sales of Herbal/Traditional Products by Category: Value 2019-2024
- Table 55. Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2019-2024
HEADLINES
PROSPECTS
- Changing reimbursement regulations provide a boost to NRT smoking cessation aids
- Rising tax levels and ban on menthol cigarettes could provide further impetus to NRT smoking cessation aids sales
- Competition from e-vapour products
COMPETITIVE LANDSCAPE
- Laboratoires Pierre Fabre and Johnson & Johnson are the clear leaders
- NiQuitin and Nicotinell are struggling
- Competition with other treatments
CATEGORY INDICATORS
- Table 56. Number of Smokers by Gender 2014-2019
CATEGORY DATA
- Table 57. Sales of NRT Smoking Cessation Aids by Category: Value 2014-2019
- Table 58. Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2014-2019
- Table 59. NBO Company Shares of NRT Smoking Cessation Aids: % Value 2015-2019
- Table 60. LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2016-2019
- Table 61. Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2019-2024
- Table 62. Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2019-2024
HEADLINES
PROSPECTS
- Falling birth rate and concerns about product safety could hit sales
- Warmer/shorter winters and fewer coughs and colds will always negatively affect sales
- The trend towards natural products is even more evident in paediatric consumer health
COMPETITIVE LANDSCAPE
- Sanofi leads but is losing share due to Mitosyl's falling sales
- Merck and Arkopharma lead paediatric vitamins and dietary supplements
- Innovation relatively limited, although Pediakid has been launching new gum formats
CATEGORY DATA
- Table 63. Sales of Paediatric Consumer Health by Category: Value 2014-2019
- Table 64. Sales of Paediatric Consumer Health by Category: % Value Growth 2014-2019
- Table 65. Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2016-2019
- Table 66. NBO Company Shares of Paediatric Consumer Health: % Value 2015-2019
- Table 67. LBN Brand Shares of Paediatric Consumer Health: % Value 2016-2019
- Table 68. Forecast Sales of Paediatric Consumer Health by Category: Value 2019-2024
- Table 69. Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2019-2024
HEADLINES
PROSPECTS
- Modern problem of sleep disorders makes sleep aids a dynamic category
- Discounts and offers key in sleep aids
- Melatonin is becoming increasingly controversial
COMPETITIVE LANDSCAPE
- All the main players in sleep aids record strong sales growth in 2019
- Popularity of herbal ingredients among consumers
- Magnesium and vitamin B also being used in products like Magnevie
CATEGORY DATA
- Table 70. Sales of Sleep Aids: Value 2014-2019
- Table 71. Sales of Sleep Aids: % Value Growth 2014-2019
- Table 72. NBO Company Shares of Sleep Aids: % Value 2015-2019
- Table 73. LBN Brand Shares of Sleep Aids: % Value 2016-2019
- Table 74. Forecast Sales of Sleep Aids: Value 2019-2024
- Table 75. Forecast Sales of Sleep Aids: % Value Growth 2019-2024
HEADLINES
PROSPECTS
- Sports nutrition thriving due to growing consumer base and wider distribution
- Despite widening distribution, gyms still an important channel for sports nutrition
- Many innovations in sports nutrition
COMPETITIVE LANDSCAPE
- Myprotein the leading brand in what is a highly competitive category
- Private label and internet retailing both have a role to play in sports nutrition
- Omnichannel sales being used to widen distribution and increase sales
CATEGORY DATA
- Table 76. Sales of Sports Nutrition by Category: Value 2014-2019
- Table 77. Sales of Sports Nutrition by Category: % Value Growth 2014-2019
- Table 78. NBO Company Shares of Sports Nutrition: % Value 2015-2019
- Table 79. LBN Brand Shares of Sports Nutrition: % Value 2016-2019
- Table 80. Forecast Sales of Sports Nutrition by Category: Value 2019-2024
- Table 81. Forecast Sales of Sports Nutrition by Category: % Value Growth 2019-2024
HEADLINES
PROSPECTS
- Vitamins continues to grow as the products fill any nutritional gaps in people's diets
- Vitamins for children is showing a positive development
- Multivitamins will continue outperforming single vitamins in the forecast period
COMPETITIVE LANDSCAPE
- Laboratories Juvat adds "superfood" products to its already extensive range
- Les Bio Freres offering vegan/vegetarian vitamins
- Bayer Sante Familiale a strong leader in multivitamins
CATEGORY DATA
- Table 82. Sales of Vitamins by Category: Value 2014-2019
- Table 83. Sales of Vitamins by Category: % Value Growth 2014-2019
- Table 84. Sales of Multivitamins by Positioning: % Value 2014-2019
- Table 85. NBO Company Shares of Vitamins: % Value 2015-2019
- Table 86. LBN Brand Shares of Vitamins: % Value 2016-2019
- Table 87. Forecast Sales of Vitamins by Category: Value 2019-2024
- Table 88. Forecast Sales of Vitamins by Category: % Value Growth 2019-2024
HEADLINES
PROSPECTS
- Meal replacement and weight loss supplements have fallen out of favour
- Slimming teas continues to record positive growth
- Weight loss vitamins and dietary supplements also suffering
COMPETITIVE LANDSCAPE
- Nutrition & Sante maintains its clear lead in weight management and wellbeing
- Nutravalia's Anaca 3 range continues to gain significant share in 2019
- Groupe Lea Nature targets development in specialised channels with the Biopur brand
CATEGORY DATA
- Table 89. Sales of Weight Management and Wellbeing by Category: Value 2014-2019
- Table 90. Sales of Weight Management and Wellbeing by Category: % Value Growth 2014-2019
- Table 91. NBO Company Shares of Weight Management and Wellbeing: % Value 2015-2019
- Table 92. LBN Brand Shares of Weight Management and Wellbeing: % Value 2016-2019
- Table 93. Forecast Sales of Weight Management and Wellbeing by Category: Value 2019-2024
- Table 94. Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2019-2024
HEADLINES
PROSPECTS
- Modest growth in a mature wound care category
- Innovation key to keeping mature wound care category moving
- Demographic trends will work for and against wound care
COMPETITIVE LANDSCAPE
- Number one player Laboratoires URGO continues growing in 2019 thanks to innovations like Urgostart Plus
- Players continue to innovate in a mature category
- Wound care is one of private label's biggest categories in consumer health
CATEGORY DATA
- Table 95. Sales of Wound Care by Category: Value 2014-2019
- Table 96. Sales of Wound Care by Category: % Value Growth 2014-2019
- Table 97. NBO Company Shares of Wound Care: % Value 2015-2019
- Table 98. LBN Brand Shares of Wound Care: % Value 2016-2019
- Table 99. Forecast Sales of Wound Care by Category: Value 2019-2024
- Table 100. Forecast Sales of Wound Care by Category: % Value Growth 2019-2024
